Early Rehab With VR for First-time Acute Stroke

Sponsor
National Defense Medical Center, Taiwan (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05929742
Collaborator
(none)
38
1
2
80
0.5

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to confirm the efficacy and feasibility of early rehabilitation combined with virtual reality training in patients following first-time acute stroke. The main questions it aims to answer are:

  • The impact of virtual reality training on muscle strength;

  • The impact of virtual reality training on functional recovery;

  • The impact of virtual reality training on mood state.

Researchers will compare the experimental group, which received early rehabilitation combined with VR training, and the comparison group, which received only early rehabilitation, to see if VR training has clinical benefits when provided alongside early rehabilitation during hospitalization.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: virtual reality training
  • Behavioral: early rehabilitation
N/A

Detailed Description

Early rehabilitation has been shown to enhance outcomes for patients with first-time acute stroke. However, whether the addition of virtual reality (VR) training could further improve muscle strength, functional recovery, and mood state for these patients is unknown. Therefore, this study aimed to investigate the effectiveness of early rehabilitation combined with VR training in patients following first-time acute stroke. Patients with acute ischemic stroke will be selected and randomly assigned with a 1:1 randomization ratio to either the experimental group or the comparison group. Both groups received early rehabilitation, and the experimental group received extra VR training starting 24 hours to 3 days poststroke during the stay in the hospital. Muscle strength, functional status, and mood state will be collected before and after the intervention.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
38 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants were divided into two groups: the experimental group, which received early rehabilitation combined with VR training, and the comparison group, which received only early rehabilitation.Participants were divided into two groups: the experimental group, which received early rehabilitation combined with VR training, and the comparison group, which received only early rehabilitation.
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Efficacy of Early Rehabilitation Combined With Virtual Reality Training in Patients With First-time Acute Stroke
Actual Study Start Date :
Apr 12, 2017
Anticipated Primary Completion Date :
Aug 12, 2023
Anticipated Study Completion Date :
Dec 12, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: experimental group

received early rehabilitation combined with VR training

Behavioral: virtual reality training
The experimental group received five additional days of supervised VR training using a wireless sensor in a private room in the neurological care ward.

Behavioral: early rehabilitation
Five 60-minute sessions per week, was prescribed by a rehabilitation physician and performed by physical, occupational, and speech therapists from 3 to 6 days after admission.

Active Comparator: comparison group

received only early rehabilitation

Behavioral: early rehabilitation
Five 60-minute sessions per week, was prescribed by a rehabilitation physician and performed by physical, occupational, and speech therapists from 3 to 6 days after admission.

Outcome Measures

Primary Outcome Measures

  1. muscle strength [through the admission period, an average of 1 month]

    The testing involved assessing the patient's upper and lower limb/extremities muscles against the examiner's resistance and grading the patient's strength on a 0-5 scale, higher scores mean a better outcome.

  2. postural control [through the admission period, an average of 1 month]

    The Postural Assessment Scale for Stroke (PASS), consisting of two sections with a 4-point scale, with 0 being the lowest level of functionality and 3 the highest, and a total score ranging from 0-36, is a well-validated clinical assessment tool for postural control in patients with stroke during the first three months after stroke.

  3. activities of daily living [through the admission period, an average of 1 month]

    The Barthel scale used to assess individuals' performance in activities of daily living has high inter-rater reliability and test-retest reliability as well as high correlations with other measures of physical disability. The scores of the 10-item Barthel scale range from 0-100 with 5-point increments. Patients with higher scores are more independent than those with lower scores in their daily activities.

  4. mood state [through the admission period, an average of 1 month]

    Mood state was assessed by the Hospital Anxiety and Depression Scale (HADS). This well-validated tool has 14 items (7 items related to anxiety [HADS-A] and 7 related to depression [HADS-D]). Each item of the HADS is scored from 0-3, and the range is 0-21 for depression and anxiety. Participants with higher scores represent a higher level of depression or anxiety. A cut-off point of 8 has been identified for anxiety or depression.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • first-time acute infarction (ischemic stroke);

  • admission to the hospital within three days of stroke onset;

  • able to communicate with verbal or nonverbal methods and understand Mandarin;

  • had a disability that ranged from minimal to moderately severe disability and evaluated as 1-4 scores by the modified Rankin Scale (mRS);

  • agree to be randomized.

Exclusion Criteria:
  • diagnosis of global aphasia, transient ischemic attack, visual or auditory impairment;

  • mRS over 5 (severe disability: requires constant nursing care and attention, bedridden, incontinent);

  • a history of cancer, end-stage renal disease with dialysis, dementia, mental health disorders (particularly major depression), based on both of medical records and assessments from the neurologist;

  • being unable to participate due to other comorbid neurological and musculoskeletal conditions that produce moderate-to-severe physical disability;

  • prolonged stay in hospital for over three weeks due to other medical diseases (e.g., myocardial infarction, septic shock, cancer) after admission or length of stay in hospital less than one week due to a decline to treatment and transferred to another hospital for further confirmation of diagnosis and other complementary or alternative therapies.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tri-Service General Hospital, National Defense Medical Center Taipei Taiwan 114

Sponsors and Collaborators

  • National Defense Medical Center, Taiwan

Investigators

  • Study Director: Shang-Lin Chiang, MD, PHD, Tri-Service General Hospital, National Defense Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ta-Chung Chao, Doctor, National Defense Medical Center, Taiwan
ClinicalTrials.gov Identifier:
NCT05929742
Other Study ID Numbers:
  • 001-VR
First Posted:
Jul 3, 2023
Last Update Posted:
Jul 3, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ta-Chung Chao, Doctor, National Defense Medical Center, Taiwan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 3, 2023